ARTICLE | Company News
Arcion, BioDelivery deal
April 1, 2013 7:00 AM UTC
Arcion granted BioDelivery exclusive, worldwide rights to develop and commercialize topical clonidine gel (formerly ARC-4558). Arcion will receive $2 million in BioDelivery common stock up front and...